# A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL

> **NCT07172893** · PHASE4 · RECRUITING · sponsor: **HealthTech Wound Care** · enrollment: 150 (estimated)

## Conditions studied

- Diabetic Foot Ulcer (DFU)
- Venous Leg Ulcer (VLU)

## Interventions

- **BIOLOGICAL:** DermaBind TL

## Key facts

- **NCT ID:** NCT07172893
- **Lead sponsor:** HealthTech Wound Care
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2027-02-21
- **Final completion:** 2027-05-21
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07172893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07172893, "A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07172893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*